{
  "basic_data": [
    {
      "cell_line_alt_name": "MO54-2",
      "cell_type": "iPSC",
      "frozen": "False",
      "hpscreg_name": "UOWi007-A"
    }
  ],
  "generator": [
    {
      "group": "Illawarra Health and Medical Research Institute, University of Wollongong"
    }
  ],
  "contact": [
    {
      "first_name": "Lezanne",
      "name_initials": "L",
      "e_mail": "lezanne@uow.edu.au",
      "last_name": "Ooi",
      "group": "Illawarra Health and Medical Research Institute, University of Wollongong"
    }
  ],
  "publications": [
    {
      "last_author": "et al.",
      "year": "2020.0",
      "first_author": "Rachelle Balez",
      "doi": "10.1016/j.scr.2020.101701",
      "journal": "Stem Cell Research",
      "title": "The mRNA-based reprogramming of fibroblasts from a SOD1E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007"
    }
  ],
  "donor": [
    {
      "sex": "Male",
      "age": "A43",
      "disease_description": "heterozygous for SOD1E101G mutation",
      "disease_name": "Amyotrophic Lateral Sclerosis"
    }
  ],
  "genomic_modifications": [
    {
      "loci_name": "SOD1E101G",
      "mutation_type": "VA"
    }
  ],
  "genomic_characterisation": [
    {
      "karyotype": "46,XY",
      "summary": "18 sites tested, matched",
      "karyotype_method": "G-banding"
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_origin_term": "Skin",
      "derivation_year": "2019",
      "i_source_cell_type_term": "Fibroblasts"
    }
  ]
}